Skip to content

Return on equity at other companies

AdaptHealth logo
AdaptHealthAHCO
-5.2%-10.8pp
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-74.6%-90.1pp
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
8.5%-1.9pp
ResMed logo
ResMedRMD
25.2%-0.6pp
UFP Technologies logo
UFP TechnologiesUFPT
17.2%-2.2pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s return on equity?
Viemed Healthcare, Inc. (VMD) reported return on equity of 10.7% in Q1 2026.
How has Viemed Healthcare, Inc.'s return on equity changed year-over-year?
Viemed Healthcare, Inc.'s return on equity increased by 9.2% year-over-year, from 9.8% to 10.7%.
What is the long-term trend for Viemed Healthcare, Inc.'s return on equity?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s return on equity has grown at a -26.3% compound annual growth rate (CAGR), from 50.3% to 10.9%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.